Morgan Stanley’s Tevogen Inc TVGN Stock Holding History

Morgan Stanley’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$106K	Buy	18,809 +1,475	+9%	+$11.8K	﹤0.01%	6226
2026 Q1	$78.3K	Buy	17,334 +12,329	+246%	+$151K	﹤0.01%	6254
2025 Q4	$82.9K	Buy	5,005 +2,472	+98%	+$64.3K	﹤0.01%	6270
2025 Q3	$99.5K	Sell	2,533 -445	-15%	-$21.9K	﹤0.01%	6155
2025 Q2	$186K	Buy	2,978 +1,660	+126%	+$94.6K	﹤0.01%	5882
2025 Q1	$71.2K	Sell	1,318 -263	-17%	-$17.3K	﹤0.01%	6157
2024 Q4	$81.4K	Buy	1,581 +582	+58%	+$37.9K	﹤0.01%	6135
2024 Q3	$18.4K	Buy	999 +585	+141%	+$17.1K	﹤0.01%	6531
2024 Q2	$15K	Buy	+414	New	+$27K	﹤0.01%	6546
2023 Q2	–	Hold	0	–	-$11	–	7707
2023 Q1	–	Hold	0	–	–	–	7659

Other funds holding TVGN

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Morgan Stanley's TVGN Position: Q2 2026 in Review

Morgan Stanley increased its Tevogen Inc (TVGN) stake by 8.5% in Q2 2026, buying an estimated $11.8K and bringing the position to 18,809 shares worth $106K. The position accounts for ﹤0.01% of the portfolio, ranked #6226.

Morgan Stanley first reported a position in TVGN in Q2 2024 and has held it in 9 quarters since. The position peaked at $186K in Q2 2025. 30 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

Morgan Stanley held 18,809 shares of Tevogen Inc worth $106K as of Q2 2026.
Morgan Stanley bought 1,475 Tevogen Inc shares in Q2 2026, an estimated $11.8K.
Tevogen Inc made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6226 holding.
Morgan Stanley first reported a position in Tevogen Inc in Q2 2024 and has held it in 9 quarters since.
Morgan Stanley's Tevogen Inc position peaked at $186K in Q2 2025.
30 funds tracked by Wall St. Rank held Tevogen Inc as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.